GlassScriptPhysician profile
David M Adelman
NPI 1457541500
$404,778.49
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $54K · 2021: $65K · 2022: $106K · 2023: $27K · 2024: $47K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Travel and Lodging: $12K · Food and Beverage: $3,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,200.00 |
| Travel and Lodging | $11,588.71 |
| Food and Beverage | $3,587.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $386,966.31 | 2019-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Tei Biosciences INC | $15,091.71 | 2019 | |
| Mentor Worldwide LLC | $951.98 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $595.83 | 2023-2025 | |
| Baxter Healthcare | $357.72 | 2019-2025 | |
| Depuy Synthes Sales INC. | $289.56 | 2024 | Na, Matrixcombo |
| Abbvie INC. | $188.61 | 2023 | Natrelle Saline-Filled Breast Implants |
| Innovation Technologies INC | $158.33 | 2025 | Irrisept |
| Sientra, INC. | $124.25 | 2020 | |
| Tepha INC | $35.41 | 2019 | |
| Tela Bio, INC. | $18.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Adelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.